| 2022-06-03 | Sale | Akebia Therapeutics, Inc. AKBA | 4,567 0.0022% | $0.36 | $1,653 | +3.54% | ||
| 2022-04-29 | Sale | Vericel Corporation VCEL | 900 0.0021% | $30.94 | $27,846 | -4.74% | ||
| 2021-11-29 | Sale | Vericel Corporation VCEL | director | 10,000 0.0226% | $39.17 | $391,710 | -23.59% | |
| 2021-10-27 | Sale | Vericel Corporation VCEL | director | 10,000 0.0215% | $50.57 | $505,740 | -37.19% | |
| 2021-09-30 | Sale | Vericel Corporation VCEL | director | 10,000 0.0215% | $48.85 | $488,510 | -30.26% | |
| 2021-06-07 | Sale | Akebia Therapeutics, Inc. AKBA | director | 4,567 0.0027% | $3.32 | $15,163 | -26.45% | |
| 2020-12-21 | SCYNEXIS, Inc. SCYX | director | 4,000 0.038% | $6.25 | $25,000 | +18.08% | ||
| 2020-06-05 | Sale | Akebia Therapeutics, Inc. AKBA | director | 4,567 0.0034% | $12.08 | $55,169 | -72.23% | |
| 2019-11-20 | Akebia Therapeutics, Inc. AKBA | director | 5,800 0.005% | $3.43 | $19,894 | +130.84% | ||
| 2019-05-01 | Sale | Vericel Corporation VCEL | director | 15,000 0.0345% | $16.81 | $252,189 | +0.9% | |
| 2019-02-28 | Sale | Vericel Corporation VCEL | director | 15,000 0.033% | $18.02 | $270,258 | -7.32% | |
| 2018-12-03 | Sale | Vericel Corporation VCEL | director | 17,000 0.0233% | $10.19 | $173,263 | -5.75% | |
| 2018-09-04 | Sale | Vericel Corporation VCEL | director | 18,000 0.0264% | $7.33 | $131,940 | +47.47% |